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the V02-PVA relation (59%. increase in INT with EMD vs 44% with DOB;
neither drug altered EFF) with normal PH.Acidosis decreased E~8Xby 22%,
increased INT by 14%, but did not change EFF [43 & 12 (SD) vs 38 +
13]. During acidosis, coronary flow increased (69%) with EMD, but was un-
changed with DOB. Compared to DOB, EMD resulted in greater increases
in both Emu (73Y0vs 24X.) and INT (I09Y0 vs 18%) but neither drug altered
EFF.Incontrast, contractile economy (l/slope of FTI-V02 relation) increased
(49%) with EMD but decreased (14%) with DOB with both normal pH and
acidosis. Conclusion: EMD is a more potent inotropic drug than DOB dur-
ing acidosis. In terms of contractile EFF, EMD does not have an energetic
advantage over DOB. However, its effects are more economical.
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809-2 The Ne+-Channel-Modulatora BDF 9148 and DPI
201-108 Exert Poaitive Inotropic Effect Without
Direct Interaction With the Contractile Proteina on
Human Myocardium
K. Brixius, C. Zobel, J. Muller-Ehmsen, H. Reuter, M. Pietsch, K. Frank,
R.H.G. Schwinger. K/inik/// furktnere Medizin, KWr, Germany
Only in right ventricular myooardium from patients with dilated cardiomyopa-
thy, but not from nonfailing patients, a Ca2+-sensitizing effect of DPI 201-106
has been described (J Clin Invest (1988) 82: 1578). The present study in-
vestigated the effect of the Na+-channel-modulators BDF 9148 (BDF, 1 MM)
and DPI 201-106 (DPI, 1 KM) on the Ca2+-sensitivity of chemically skinned
(Triton X, 1%, 20 h, 4’C) left ventricular muscle fibers (SFB) from patients
with dilated cardiomyopathy (DCM, n =8) and nonfailing patients (NF,n = 7).
For comparison, the Caz+-sensitizer EMD 57033 (EMD, 10 KM) was studied
as well.
In electrically stimulated left ventricular papillary muacle strips (1.6 mM
Ca2+, 1 Hz) from NF end DCM BDF, DPI and EMD significantly increased
force”of coritraction. In SFB EMD shifted the concentra~icm-responeecuwe
significantly to the left in DCM (95% confidential interval of EC50(Cl ECW):
control: 2.0-2.4 wM; +EMD: 0.5-1.0 PM) and NF (Cl EC50:2.6-3.5; +EMD:
0.4-0.7 PM). BDF and DPI did not influence the Caz+-sensitivity of the
contractile proteins towards Ca2+ in DCM and in nonfailing myocardium.
It is concluded, that (1) Caz+-sensitizere increase the sensitivity of the
contractile proteins towards Ca2+ in DCM and in nonfailing myocardium; (2)
BDF 9146 and DPI 201-106 increase force of contraction without increasing
the Ca2+-sensitivity of the contractile apparatus in man.
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r8fJ9-3] hlechanimaofthe,~~-l poaitive,onotropic~ction
A. Cittadini, M. Spindler, H. Stromer, Y. Ishiguro, K.E. Travers, J.S. Ingwall,
J.P. Morgan. Harvard Medical School, Boston, MA, USA
Although chronic treatment with insulin-like growth factor-1 (IGF-1) is known
to increase cardiac function in humans and rats, its acute cardiac effects
and mechanisms of atiion are largely obacure. IGF-I was acutely admin-
istered in isovolumic buffer-perfused whole hearl preparations monitoring
functional indexes, and peak intracellular calcium levels, [Ca2+]i,with the ae-
quorin bioluminescence method. Ca2+ responsiveness of the myofilaments
was assessed by determining the maximal Ca2+activated pressure (MCAP)
and the ECW of the peak Ca2+-peak LV pressure relationship. 3’P NMR
spectroscopy was used to assess intracellular pH, [pH]i, and high energy
phosphate metabolism. The maximal positive inotropic effect of IGF-1, ob-
served ataconcentration of 10-7, was evident within 60s after the application
and persisted after its removal from the perfusate.
Data are mean 4 SE; DP = developed pressure; *p c 0.01 vs. baseline.
DP [Ca2+]j MCAP ECSO [PH]i
mmHg pmo!JL mmHg fimollL pH units
aaeeline 124 &4 0.76 k 0.01 173 *8 0.68 + 0.02 7.15 * 0,01
IGF-1 150+ 3* 0.74+ O.01* 215+5* 0.66+ 0.02 7.15+ 0.01
IGF-I increased DP by 21% from baseline. This positive inotropic effect
was mediated by an increase in myofilaments Ca2+ responsiveness, in
particular by an increase in MCAP since [Ca2+]t decreased. [pH]i and high
energy phosphate content did not change during IGF-1 infusion. IGF-I is a
drug with unique properties, acting primarily by sensitizing the myofilaments
to Ca2+without modifying high energy phosphate metabolism.
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LY366634, a Novel Sodium Channel Activator,
Improves Left Ventricular Function in Dogs With
Chronic Heart Failure
M. Tanimure, S. Shevlyagin, H. Shimoyama, Ml. Steinberg 1, S. Borzak,
S. Goldstein, H.N. Sabbah. Henry Ford Hear?end Vascu/ar/nstitute, Detroit,
Ml, USA, 1Lily Research Laboratories, Indianapolis, IN, USA
The hemodynamic effects of LY386634 (LY) (chemical name: (s)-4-[3-[[l-(di-
phenylmethyl)-3-azetidinyl]oxy]-2-hydroxypropoxy]-lh-indole-2-carbonitrile},
were examined in 7 dogs with chronic heart failure (HF) (LV ejection fraction
26+ 2%) produced by sequential intracoronary microembolizations. LY was
administered intravenously in incremental doses of 3, 5 and 10 @lg/min.
Each dose was administered for30 min. Heart rate (HR, rein-l), QTc interval
(msec), peak LV +dP/dt (mmHg/see) and LV fractional area of shortening
(FAS, %) were measured at baseline and at 30 minutes after the adminis-
tration of each of the 3 drug doses. FAS was meaaured from 2-D short axis
echocsrdiogrems.
Baaeline 3 @kgrmin 5 pglkglmin 10 z@lrg/mln
HR 82& 6 70’+ 6* 75* 7 70* 5
QTc 311*9 309* 7 325* 11 339* 17*
+dP/dt 1569+ 118 1929* 137” 2146+ 116* 2388+ 155*
LVFAS 27& 2 32k 2* 37* 2* 43+ 2*
*P <0.05 va, Baseline,ANOVA withStudents-Newman-Keulsteat
LY was not associated with ventricular arrhythmias. It tended to reduce
HR and had no effect on QTc interval except at the highest dose used. In
addition, LY significantly improved peak LV +dP/dt and FAS. Conclusion: in
dogs with HF,intravenous LYimproves LVsystolicfunction without increasing
HR and with little or no prolongation of QTc interval. These findings suggeat
that LY may be a useful agent for the ehort-term treatment of patients with
advanced HF.
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El8101 Post-Reauscitetion Left Ventricular Diastolic
Dysfunction Successfully Treated with Dobutemine
K.B. Kern, R.W. Hilwig, R.A. Berg, K.H. Rhee, A.B. Sanders, C.W. Otto,
G.A. Ewy. The UniversifyofArizona, Tucson,Arizone, USA
Significant left ventricular dysfunction, including both eystolic and diastolic,
has been documented following successful resuscitation from prolonged cer-
diacarrest. Successful treatment of post-resuscitation LVsystolic dysfunction
has been reported with Dobutamine (Debut). Dobutamine (10 @@rein)
was studied for ite effect on post-resuecitetion diastolic dysfunction in 14
swine. Eight additional swine were also studied as controls. Solid etate
micromanometer-tipped catheters were used for measurement of left ven-
tricular enddiastolic pressure, and the calculation of the time constant of
isovolumic relaxation (Tau). Contrast left ventriculograms were performed
to calculate left ventricular volumes. Each aniwal underwent a 15-minute
period of untreated ventricular fibrillation cardiac arrest followed by resus-
citation. Data were collected at a pre-arrest baseline and at 5-hours post
successful resuscitation. Table 1 shows the improved diastolic function at
5-hours post-resuscitation in the Dobutamine treated animals compared with
controls.
LVEDP LVEDV EDP/EDV Tau
(mmHg) (ml) (x 100) (msec)
Baseline
Controls 11 * 1 2S A 6 41 * 5 2s* 1
Debut. 11 * 1 31 l 2 38 k 4
5 Hours
31 l 1“
Controla 20+ 3 28+ 5 76* 11 41 * 3
Dobut. 9+ 1“ 25* 3 47 k 6’ 31 *5*
*ps 0.05 vs controls
Dobutamine (10 @kg/rein) can successfully overcome left ventricular
diastolic dysfunction seen 5 hrs. after successful resuscitation from cardiac
arrest.
